Progyny, Inc. PGNY
We take great care to ensure that the data presented and summarized in this overview for Progyny, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding PGNY
View all-
Black Rock Inc. New York, NY11.8MShares$162 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.64MShares$118 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX6.88MShares$94 Million2.76% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.43MShares$46.9 Million0.03% of portfolio
-
State Street Corp Boston, MA3.11MShares$42.6 Million0.0% of portfolio
-
International Assets Investment Management, LLC Orlando, FL2.57MShares$35.1 Million0.42% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.49MShares$34.1 Million0.1% of portfolio
-
Morgan Stanley New York, NY2.08MShares$28.4 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY1.95MShares$26.7 Million0.16% of portfolio
-
Geode Capital Management, LLC Boston, MA1.92MShares$26.3 Million0.0% of portfolio
Latest Institutional Activity in PGNY
Top Purchases
Top Sells
About PGNY
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Insider Transactions at PGNY
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 23
2024
|
Norman Payson Director |
SELL
Open market or private sale
|
Indirect |
200
-0.03%
|
$11,200
$56.29 P/Share
|
|
Oct 01
2024
|
David J Schlanger Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
2,681
-3.31%
|
$42,896
$16.76 P/Share
|
|
Oct 01
2024
|
Peter Anevski CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
7,977
-3.32%
|
$127,632
$16.76 P/Share
|
|
Sep 03
2024
|
Michael E Sturmer PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
448
-0.13%
|
$10,304
$23.49 P/Share
|
|
Sep 03
2024
|
Mark S. Livingston CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,617
-5.56%
|
$60,191
$23.49 P/Share
|
|
Aug 28
2024
|
Allison Swartz EVP, GC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,352
-2.03%
|
$28,392
$21.59 P/Share
|
|
Aug 26
2024
|
Michael E Sturmer PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
7,977
-2.2%
|
$167,517
$21.8 P/Share
|
|
Aug 26
2024
|
Mark S. Livingston CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
224
-0.47%
|
$4,704
$21.8 P/Share
|
|
Jul 16
2024
|
Michael E Sturmer PRESIDENT |
SELL
Open market or private sale
|
Direct |
9,030
-2.43%
|
$270,900
$30.0 P/Share
|
|
Jul 01
2024
|
David J Schlanger Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
2,681
-3.21%
|
$75,068
$28.61 P/Share
|
|
Jul 01
2024
|
Peter Anevski CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
7,977
-3.22%
|
$223,356
$28.61 P/Share
|
|
Jun 28
2024
|
Cheryl Scott Director |
SELL
Open market or private sale
|
Direct |
1,462
-12.65%
|
$40,936
$28.39 P/Share
|
|
Jun 03
2024
|
Michael E Sturmer PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
448
-0.12%
|
$11,648
$26.95 P/Share
|
|
Jun 03
2024
|
Mark S. Livingston CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,617
-5.25%
|
$68,042
$26.95 P/Share
|
|
May 28
2024
|
Allison Swartz EVP, GC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,352
-1.99%
|
$36,504
$27.0 P/Share
|
|
May 28
2024
|
Mark S. Livingston CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
224
-0.45%
|
$6,048
$27.0 P/Share
|
|
May 28
2024
|
Michael E Sturmer PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
7,977
-2.1%
|
$215,379
$27.0 P/Share
|
|
May 23
2024
|
Beth C Seidenberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,206
+14.23%
|
-
|
|
May 23
2024
|
Kevin K Gordon Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,147
+36.9%
|
-
|
|
May 23
2024
|
Lloyd H Dean Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,147
+30.55%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 493K shares |
|---|---|
| Exercise of conversion of derivative security | 692K shares |
| Open market or private sale | 698K shares |
|---|---|
| Payment of exercise price or tax liability | 252K shares |
| Bona fide gift | 3.33K shares |